CLINICAL TRIALS PROFILE FOR NATEGLINIDE
✉ Email this page to a colleague
All Clinical Trials for nateglinide
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00097786 ↗ | Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications | Completed | Novartis Pharmaceuticals | Phase 3 | 2002-01-01 | This study is a test of the safety and effectiveness of two drugs, one for diabetes and one for hypertension, in keeping patients with high lab values of glucose from progressing to frank diabetes and developing cardiovascular complications. People in this study cannot have frank diabetes but are considered "borderline" based on blood tests. People in the study take none, one or both of the drugs and do not know which one(s) they are taking. |
NCT00189774 ↗ | Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients | Completed | Ajinomoto USA, INC. | Phase 2/Phase 3 | 1969-12-31 | The purpose of this study is to investigate the superiority of nateglinide over placebo for inadequately controlled type 2 diabetic patients with pioglitazone treatment. |
NCT00189774 ↗ | Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients | Completed | Astellas Pharma Inc | Phase 2/Phase 3 | 1969-12-31 | The purpose of this study is to investigate the superiority of nateglinide over placebo for inadequately controlled type 2 diabetic patients with pioglitazone treatment. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for nateglinide
Condition Name
Clinical Trial Locations for nateglinide
Trials by Country
Clinical Trial Progress for nateglinide
Clinical Trial Phase
Clinical Trial Sponsors for nateglinide
Sponsor Name